The Potential of microRNAs for Stem Cell-based Therapy for Degenerative Skeletal Diseases
- PMID: 29214143
- PMCID: PMC5700219
- DOI: 10.1007/s40610-017-0076-4
The Potential of microRNAs for Stem Cell-based Therapy for Degenerative Skeletal Diseases
Abstract
Purpose of review: Degenerative skeletal disorders including osteoarthritis (OA) and osteoporosis (OP) are the result of attenuation of tissue regeneration and lead to painful conditions with limited treatment options. Preventative measures to limit the onset of OA and OP remain a significant unmet clinical need. MicroRNAs (miRNAs) are known to be involved in the differentiation of stem cells, and in combination with stem cell therapy could induce skeletal regeneration and potentially prevent OA and OP onset.
Recent findings: The combination of stem cells and miRNA has been successful at regenerating the bone and cartilage in vivo. MiRNAs, including miR-146b known to be involved in chondrogenic differentiation, could provide innovative targets for stem cell-based therapy, for the repair of articular cartilage defects forestalling the onset of OA or in the generation of a stem cell-based therapy for OP.
Summary: This review discusses the combination of skeletal stem cells (SSCs) and candidate miRNAs for application in a cell-based therapy approach for skeletal regenerative medicine.
Keywords: Bone; Cartilage; Osteoarthritis; Osteoporosis; Skeletal stem cell; miRNA.
Conflict of interest statement
Conflict of Interest
Emma Budd, Shona Waddell, María C. de Andrés, and Richard O. C. Oreffo declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Figures

References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous